Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited (“Lumeon”), a digital health company with operations in the U.S. and United Kingdom dedicated to helping provider organizations mend broken care coordination processes through automated care orchestration.
Leading providers in the U.S. and the United Kingdom use Lumeon’s Care Orchestration technology to lower costs, optimize clinician and staff time, enhance revenue, and improve quality and patient safety. Together with Health Catalyst, this acquisition aims to leverage Lumeon’s robust and market-leading platform and make it more intelligent through the application of advanced analytics, AI, and Health Catalyst Ignite™ data processing capabilities. Health Catalyst expects this combination will further strengthen and differentiate its core focus on clinical improvement and ambulatory operations, in addition to supporting its current and future Tech-Enabled Managed Services (TEMS) partnerships.
Health Catalyst also anticipates that Lumeon’s presence in the United Kingdom will strengthen its ability to expand and more effectively pursue new opportunities in the region and potentially in other international markets.
Health Catalyst CEO Dan Burton said, “We are excited to welcome the Lumeon team and work alongside them in support of our shared mission – to enable massive, measurable, data-informed healthcare improvement. Effective care management is an essential part of a patient’s clinical care journey, and the addition of Lumeon’s Care Orchestration to Health Catalyst’s existing technology and services offering will further enhance the analytics insights made available to providers seeking to transform clinical care.”
Lumeon CEO Robbie Hughes said, “By combining the Health Catalyst Ignite AI platform with our Care Orchestration technology, we will enable healthcare organizations to not only access data-driven insights at scale but now also automate the clinical actions needed to ensure those insights are translated into personalized care processes for patients and care teams, closing the loop for data-driven transformation and accelerating our shared flywheel further and faster than ever before.”
Health Catalyst funded the transaction with a mix of stock and cash. Additional details regarding the acquisition were included in Health Catalyst’s Quarterly Report on Form 10-Q for the fiscal quarter that ended June 30, 2024, and was filed with the Securities and Exchange Commission (“SEC”) on August 7, 2024.
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!
